280
Participants
Start Date
August 31, 2007
Primary Completion Date
April 30, 2008
Study Completion Date
May 31, 2008
PS433540
200mg capsule, once daily for 28 days
placebo
placebo capsule, once daily for 28 days
PS433540
500mg capsule, once daily for 28 days
MD Medical Research, Oxon Hill
University Clinical Research Deland, LLC, DeLand
Alan Graff, MD PA, Fort Lauderdale
Lindner Clinical Trial Center, Cincinnati
Gemini Scientific, Madison
Orland Primary Care Specialists, Orland Park
Cedar Crosse Research Center, Chicago
Punzi Medical Center, Carrolton
Premiere Pharmaceutical Research, LLC, Tempe
National Research Institute, Los Angeles
Long Beach Center for Clinical Research, Long Beach
Westlake Medical Center, Westlake Village
Orange County Research Center, Tustin
Clinical Trials Research, Lincoln
Sacramento Research Medical Group, Sacramento
Lead Sponsor
Ligand Pharmaceuticals
INDUSTRY